INTERINDIVIDUAL DIFFERENCES IN NICOTINE METABOLISM AND GENETIC POLYMORPHISMS OF HUMAN CYP2A6

This publication has 42 references indexed in Scilit:

• An in Vivo Pilot Study Characterizing the New CYP2A6*7, *8, and *10 Alleles
  Biochemical and Biophysical Research Communications, 2002
• CYP2A6*6, a Novel Polymorphism in Cytochrome P450 2A6, Has a Single Amino Acid Substitution (R128Q) That Inactivates Enzymatic Activity
  Published by Elsevier ,2001
• A Novel Single Nucleotide Polymorphism Altering Stability and Activity of CYP2A6
  Biochemical and Biophysical Research Communications, 2001
• Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism
  FEBS Letters, 1999
• The Significance of the Homozygous CYP2A6 Deletion on Nicotine Metabolism: A New Genotyping Method of CYP2A6 Using a Single PCR–RFLP
  Biochemical and Biophysical Research Communications, 1999
• Low frequency of CYP2A6 gene polymorphism as revealed by a one-step polymerase chain reaction method
  Pharmacogenetics, 1999
• CYP2A6 gene polymorphism and risk of liver cancer and cirrhosis
  Pharmacogenetics, 1997
• The CYP2 A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesis
  Pharmacogenetics, 1995
• Poor metabolisers of nicotine and CYP2D6 polymorphism
  The Lancet, 1994
• Pharmacologic Aspects of Cigarette Smoking and Nicotine Addiction
  New England Journal of Medicine, 1988